Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Non-Current Assets (2016 - 2026)

SANUWAVE Health has reported Non-Current Assets over the past 17 years, most recently at $13.1 million for Q1 2026.

  • Quarterly Non-Current Assets rose 9.29% to $13.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $13.1 million through Mar 2026, up 9.29% year-over-year, with the annual reading at $12.7 million for FY2025, 8.48% up from the prior year.
  • Non-Current Assets was $13.1 million for Q1 2026 at SANUWAVE Health, up from $12.7 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $13.6 million in Q1 2022 and troughed at $11.7 million in Q4 2024.
  • The 5-year median for Non-Current Assets is $12.9 million (2023), against an average of $12.8 million.
  • Year-over-year, Non-Current Assets decreased 10.0% in 2022 and then grew 9.29% in 2026.
  • A 5-year view of Non-Current Assets shows it stood at $13.3 million in 2022, then decreased by 4.69% to $12.6 million in 2023, then fell by 7.2% to $11.7 million in 2024, then increased by 8.48% to $12.7 million in 2025, then increased by 3.34% to $13.1 million in 2026.
  • Per Business Quant, the three most recent readings for SNWV's Non-Current Assets are $13.1 million (Q1 2026), $12.7 million (Q4 2025), and $13.0 million (Q3 2025).